These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22130287)

  • 1. Relationship between serum phosphorus and the progression of advanced chronic kidney disease.
    Caravaca F; Villa J; García de Vinuesa E; Martínez del Viejo C; Martínez Gallardo R; Macías R; Ferreira F; Cerezo I; Hernández-Gallego R
    Nefrologia; 2011; 31(6):707-15. PubMed ID: 22130287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
    Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
    Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease.
    Cottone S; Palermo A; Arsena R; Riccobene R; Guarneri M; Mulè G; Tornese F; Altieri C; Vaccaro F; Previti A; Cerasola G
    J Nephrol; 2010; 23(1):62-9. PubMed ID: 20091488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
    Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
    Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease.
    Chue CD; Edwards NC; Davis LJ; Steeds RP; Townend JN; Ferro CJ
    Nephrol Dial Transplant; 2011 Aug; 26(8):2576-82. PubMed ID: 21248296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors related with the progression of chronic kidney disease.
    Yuste C; Barraca D; Aragoncillo-Sauco I; Vega-Martínez A; Abad S; Verdalles-Guzmán Ú; Ruiz-Caro C; Ampuero J; López-Gómez JM
    Nefrologia; 2013; 33(5):685-91. PubMed ID: 24089160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.